netFormulary NHS
North Central London
Joint Formulary
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
Chapter Links...
Link   RFL: Guidelines for Acute Pain Management in Adults
 Details...
04.04  Expand sub section  CNS stimulants and other drugs used for attention deficit hyperactivity disorder
Atomoxetine
View adult BNF View SPC online View childrens BNF 		Restricted Drug Restricted
GP - Amber
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to the Child & Adolescent Mental Health Service only  
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    •  As per NICE TA98 / CG87
  • CIFT
    • Approved for adults with ADHD (off-label)
  • BEHMT
    • Approved for adults with ADHD (off-label)
 
Link  NCL JFC: Adult ADHD shared care guideline
Link  NICE TA98: Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Dexamfetamine
View adult BNF View SPC online View childrens BNF 		Formulary
GP - Amber
AAAAAAAA

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Restricted to the Sleep Clinic for narcolepsy
    • Restricted to CAMS for ADHD in children and adolescents  
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    •  As per NICE TA98 / CG87
  • CIFT
    • Approved for adults with ADHD (off-label) - 3rd line after methylphenidate and lisdexamphetamine
  • BEHMT
    • Approved for adults with ADHD (off-label)
 
Link  NCL JFC: Adult ADHD shared care guideline
Link  NICE TA98: Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Lisdexamfetamine
View adult BNF View SPC online View childrens BNF 		Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
  • CIFT:
    • Approved for adults with ADHD (off-label) - 1st line (joint with methylphenidate)
  • BEHMT:
    • Approved for adults with ADHD (off-label)

 

 

 
Methylphenidate hydrochloride
(Concerta®XL)
View adult BNF View SPC online View childrens BNF 		Restricted Drug Restricted
GP - Amber
AAAAAAAA

Approved for ADHD (JFC February 2019).

Provider notes

  • NMUH:
    • For continuation only for ADHD ONLY
  • RFL:
    • Restricted to the Child & Adolescent Mental Health Service only
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • As per NICE TA98 / CG87
  • CIFT
    • Approved for adults with ADHD (off-label) - 1st line
  • BEHMT
    • Approved for adults with ADHD (off-label)
 
Link  NCL JFC: Adult ADHD shared care guideline
Link  NICE TA98: Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Methylphenidate Hydrochloride
(Equasym®XL)
View adult BNF View SPC online View childrens BNF 		Restricted Drug Restricted
GP - Amber
AAAAAAAA

Approved for ADHD (JFC February 2019).

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to the Child & Adolescent Mental Health Service only
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    •  As above
  • CIFT
    • Approved for adults with ADHD (off-label) - 1st line
  • BEHMT
    • Approved for adults with ADHD (off-label)
 
Link  NCL JFC: Adult ADHD shared care guideline
Link  NICE TA98: Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Methylphenidate Hydrochloride
(Medikinet®XL)
View adult BNF View SPC online View childrens BNF 		Restricted Drug Restricted
GP - Amber
AAAAAAAA

Approved for ADHD (JFC February 2019).

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    •  As above
  • CIFT
    • Approved for adults with ADHD (off-label) - 1st line
  • BEHMT
    • Approved for adults with ADHD (off-label)
 
Link  NCL JFC: Adult ADHD shared care guideline
Link  NICE TA98: Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Modafinil
View adult BNF View SPC online View childrens BNF 		Formulary
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary  
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    •  
 
Link  NICE TA98: Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents
 link Link    NICE TA98: Attention deficit hyperactivity disorder (ADHD) - methylphenidate, atomoxetine and dexamfetamine
04.04  Expand sub section  Cocaine
 ....
 Non Formulary Items
Guanfacine

View adult BNF View SPC online View childrens BNF 		Non Formulary
Methylphenidate Hydrochloride
(Tourette's syndrome)

View adult BNF View SPC online View childrens BNF 		Non Formulary
Black

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Not approved for Tourette's syndrome (May 2017)
Methylphenidate Hydrochloride
(Delmosart® )

View adult BNF View SPC online View childrens BNF 		Non Formulary
GP - Amber
Link  NCL JFC: Adult ADHD shared care guideline
Link  NICE TA98: Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Methylphenidate Hydrochloride
(Ritalin®)

View adult BNF View SPC online View childrens BNF 		Non Formulary
GP - Amber
Link  NCL JFC: Adult ADHD shared care guideline
Link  NICE TA98: Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Methylphenidate Hydrochloride
(Xaggitin®XL)

View adult BNF View SPC online View childrens BNF 		Non Formulary
GP - Amber
Link  NCL JFC: Adult ADHD shared care guideline
Link  NICE TA98: Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
 Display tracking information
click to search medicines.org.uk
 Link to adult BNF
click to search medicines.org.uk
 Link to children's BNF
click to search medicines.org.uk
 Link to SPCs
Homecare
 Homecare

Traffic Light Status Information

Status Description

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.  

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

See link for the complete NCL Red List https://www.ncl-mon.nhs.uk/wp-content/uploads/2017/08/ncl_red_list.pdf

  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary